THE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY



Similar documents
Deakin Research Online

Diagnosis, classification and prevention of diabetes

6.4 Diabetes. 6 Priority diseases and reasons for inclusion. Background. Developments since See Background Paper 6.4 (BP6_4DM.

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Baskets of Care Diabetes Subcommittee

Type 1 Diabetes ( Juvenile Diabetes)

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

DR. Trinh Thi Kim Hue

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

Diabetes and Heart Disease

REPORT ON DIABETES i

Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes

Statistics of Type 2 Diabetes

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.

Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health

An Overview and Guide to Healthy Living with Type 2 Diabetes

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Diabetes mellitus. Lecture Outline

Mortality Associated with Diabetes

The Burden Of Diabetes And The Promise Of Biomedical Research

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Glycemic Control of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children

Jill Malcolm, Karen Moir

Guidelines for the management of hypertension in patients with diabetes mellitus

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

Introduction. Pathogenesis of type 2 diabetes

Diabetes and Obesity. The diabesity epidemic

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

Diabetes Mellitus PLAN

Shutterstock TACstock

Understanding diabetes Do the recent trials help?

Hypertension and Diabetes Status Bangladesh Demographic and Health Survey

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Post-Transplant Diabetes: What Every Patient Needs to Know

Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE

Understanding Diabetes

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

CHESHIRE EAST COUNCIL DRIVER MEDICAL

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?

Measuring and Improving the Quality of Diabetes care in General Practice. Dr M Grixti. Dr C Scalpello, Dr C Mercieca, Dr P Mangion, Dr T O Sullivan

Practical Applications of Insulin Pump Therapy in Type 2 Diabetes

THE IMPACT OF USING BLOOD SUGAR HOME MONITORING DEVICE TO CONTROL BLOOD SUGAR LEVEL IN DIABETIC PATIENTS

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease

HEALTH MANAGEMENT PLAN PROGRAMME

Management of Diabetes Mellitus among Elderly Men and Women Impact of Intervention Programme

Knowledge of diabetes mellitus amongst nursing students Effect of an intervention

Do You Know the Health Risks of Being Overweight?

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

AusDiab The Australian Diabetes, Obesity and Lifestyle Study. Tracking the Accelerating Epidemic: Its Causes and Outcomes

The Influence of Infant Health on Adult Chronic Disease

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Coronary Heart Disease (CHD) Brief

Listen to your heart: Good Cardiovascular Health for Life

TABLE OF CONTENTS. The Cost of Diabesity Employer Solutions... 4 Provide a Worksite Weight Loss Program Tailored for Diabetes...

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

Institute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES

World Kidney Day 11 March 2010: we must act on diabetic kidney disease

Primary Care Quality Care Indicators - Accuro EMR Prevention

Main Effect of Screening for Coronary Artery Disease Using CT

The Burden of the Complicated Type 2 Diabetes Patient in China. White Paper

Keywords: Guyana, type 2 diabetes, life style habits, diet, exercise, medication

Preventing Pediatric Diabetes: Are Racial Disparities A Factor? A Children s Health Fund Issue Brief February 2004

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Diabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12

How To Know If You Have Microalbuminuria

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

How To Determine The Prevalence Of Microalbuminuria

Family History and Diabetes. Practical Genomics for the Public Health Professional

Cardiovascular Disease Risk Factors

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

Know your Numbers The D5 Goals for Diabetes Care. Shelly Hanson RN, CNS, CDE Cuyuna Regional Medical Center November 6, 2014

Using electronic medical record system (EMRS) for diabetes management in Cameroon

Diabetes Questionnaire

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council

Manitoba EMR Data Extract Specifications

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

4/11/14. Medical Director, Bariatric Surgery Mountainview Regional Medical Center. ! None. ! Discuss the ongoing epidemic of obesity

Diabetes and Life Insurance. A Special Report by LifeInsure.co.uk

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

This information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.

TERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES. Definitions for Common Terms Related to Type 2 Diabetes

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

How To Prevent Type 2 Diabetes

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Diabetes Mellitus Type 2

METABOLIC SYNDROME IN A CORRECTIONS POPULATION TREATED WITH ANTIPSYCHOTICS

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

Transcription:

Analele UniversităŃii din Oradea Fascicula:Ecotoxicologie, Zootehnie şi Tehnologii de Industrie Alimentară, 2012 THE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY *University of Oradea, Faculty of Environmental Protection, Bd. Magheru 26 ioana_andravlad@yahoo.co.uk Vlad Ioana Andra * Abstract Diabetes mellitus is an extremelly important public health problem in Romania and worldwide due to its high prevalence, serious complications and at last but not the least, due to induced high costs. World Health Organisation estimated in 2000 that aproximatelly 172 mil. persons suffer from this condition representing 50% of the prevalences compared to the 1990.The prognoses show that in 2030 the level of diseased people will reach 360 mil. The proposed study presents the analysed new of diabetes detected during 2011, in Bihor county and registered in the County Sub Program for Diabetes, Metabolic and Nutrition Diseases. 2500 diabetes were detected of which 30 new pertained to type I diabetes and 2470 to type II diabetes. Data were accessed from individual patient files and transcribed into author s research files. Key words: diabetes mellitus, prevalence, complications. INTRODUCTION Diabetes mellitus is a complex and heterogeneous syndrome induced by genetically or acquired disbalance of insulin secretion or/and by the resistance of the peripheral cells to insulin action which leads to profound modifications of the protein, carbohydrate, lipid, ion and mineral metabolism [1-4]. These modifications cause chronic complications especially at eyes, kidneys, heart and blood vessels. The classical triade: polyuria, polyphagia and polydipsia are not any longer of diagnostic value due to the fact that the condition initiation is atypical or insidious. This phenomenon explains the emergence of serious, often irreversible complications [5,6]. Diabetes as condition is present worldwide. Its prevalence is continuously growing in the world and is one of the major mortality and morbidity causes [7-9]. Diabetes is one of the most frequent chronic conditions, its prevalence especially of the type II being in expansion and reaching epidemic levels worldwide. The most important causes of the prevalence are: aging of the human population, obesity, sedentary life style, the inadequate diet, urbanization and industrialization [10-12]. 439

Epidemiological research of diabetes mellitus took a rapid pace especially after World War II. Previous attempts led to several conclusions which, at large, could not be tested. The morbidity due to diabetes was based on hospital, polyclinic and private practice statistics which provided unrealistic data due to: intended or unintended bias, impossibility for the interpolation of the obtained information to large population groups, the lack of a unified and objective methodology. For the establishment of a correct morbidity in the case of diabetes as in other conditions too, an active detection is required [12-14]. MATERIAL AND METHOD The study includes the sum of newly detected type I and II diabetes in Bihor County during 2011. The data was provided by the County Sub- Program for Diabetes, Nutrition and Metabolic Diseases, Bihor County which is a part of the National Health System of Romania. In the activity of the County diabetes ambulatory center, the fundamental and specific unit of data collection is the dispensarization sheet, conceived and legislated by the Health Ministry of Romania. The first part of the observation sheet is permanently sight accessible and offers general information about the patient with appropriate identification data: first and last name, birth date, gender, personal numerical code, address and also the probable inception date of the condition, the certified date of the disease registration by confirmed diagnosis by a specialist in diabetology, social environment, also the confirmed health security status proved by the affiliation to one or several health security systems. In order to gather and process the data, a personal research sheet was provided to be filled in for every patient separately. This observation sheet contained the following data: The age of the patient The gender Social environment The weight and the height of the patient for the calculation of the body mass index. Diabetes mellitus type The chosen treatment type: diet, oral, insulin wise or both type treatments Chronic microangyopathic complications Chronic macroangyopathic complications Comorbidity: high blood pressure, dyslipidemia Systolic and diastolic arterial pressure. 440

RESULTS AND DISCUSSION The study outcome consists in the following results: during 2011, in Bihor county, 2500 new diabetes mellitus were detected of which 30 pertained to diabetes type I and 2470 to diabetes type II. From the total of 2500, 1225 were treated with oral anti-diabetes medication (OAD) and 1245 were treated with oral anti-diabetes medication and insulin (Table 1). Table 1 The repartition of dibetes mellitus according to medication type, social environment and gender, Bihor county survey 2011. Medication type No. of Of which Urban environment Rural environment Women Men OAD 1225 600 625 600 625 OAD+insulin 1245 560 685 785 460 Concerning the age of the diabetes mellitus type II inception, in Bihor county during 2011, the highest case number was recorded in the 60-70 age group (Table 2). Table 2 The repartition of dibetes mellitus according to age groups and medication type, Bihor county survey 2011 Medication type 30-40 40-50 50-60 60-70 70-80 OAD 25 175 375 250 400 1225 OAD + insulin 210 25 660 200 150 1245 Total no. of Connected to chronic complications, most frequently encountered were of macro angiopathic-coronary nature (pectoral angina, myocardial arrest) followed by chronic microangiopathic and neurological complications (diabetes induced neuropathy) (Table 3). 441

Table 3 The repartition of chronic complications induced by diabetes according to different types of medication, Bihor county survey 2011. Medication type No. of Retinopathy Neuropathy Nephropathy Cerebral complications (AVC) OAD 1225 150 425 50 100 500 OAD + 1245 300 450 175 75 275 insulin Coronary complicatio ns As function of weight and height, the index of body mass was calculated for every patient. The index indicated that a greater number of patients with diabetes type II suffered from overweight and various level obesity (Table 4). Table 4 The repartition of the body mass index according to medication type in patients suffering from diabetes, Bihor county survey 2011. Medication Total no. of Normal overweight obesity type weight OAD 1225 125 450 650 OAD + insulin 1245 160 610 475 CONCLUSIONS Diabetes mellitus is a major problem for individuals, medicine and society due to the progressive increase of worldwide, within all diabetes types and within all age groups. The aging of the human population and the modifications associated with urbanization, globalization and development increases the burden set by the diabetes all over the world, especially in the countries with low and average income where the necessary resources in order to face the associated medical problems are scarce. Actual and future estimations concerning the weight of diabetes are important for the allocation of the community and health care resources, for stressing the important role of the life style in diabetes emergence and to encourage the counteracting measures against the increasing prevalence trend. It is a straightforward link between diabetes, obesity and cardiac problems. 442

REFERENCES: 1. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. GPE discussion paper series 31. Geneva, Switzerland: World Health Organization; 2001. 2. Whiting D, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011. 3. Saaty TL. Analytic hierarchy process. In: Encyclopedia of biostatistics2nd ed., John 4. Wiley & Sons, Ltd.; 2005. 5. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Prct 2010;87:4-14. 6. Danaie G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-s and 2-7 million participants. Lancet 2011;378:31-40. 7. [King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabets Care 1993; 16 (January) :157-77. 8. [Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the 2010. Diabet Med 1997; 14 (Suppl.5): S1-85. 9. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21(9):1414-31. 10. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53. 11. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-s and 2. 7 million participants. Lancet 2011;378(July):31-40. 12. International Diabetes Federation. Diabetes atlas, 1 st ed., Brussels, Belgium: International Diabetes Federation; 2000. 13. International Diabetes Federation. Diabetes atlas, 2 nd ed., Brussels, Belgium: International Diabetes Federation; 2003. 14. International Diabetes Federation. Diabetes Atlas, 3 rd ed., Brussels, Belgium: International Diabetes Federation; 2006. 15. International Diabetes Federation. IDF Diabetes Atlas, 4 th ed., Brussels, Belgium: International Diabetes Federation; 2009. 443

444